Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Attorney warns of gainsharing risks

This article was originally published in The Gray Sheet

Executive Summary

U.S. Attorney James Sheehan warns that gainsharing is "fraught with risk" stemming from the implications of the anti-kickback statute and the Stark law in such arrangements. At the Medical Device Regulatory and Compliance Congress in Cambridge, Mass. on March 29, Sheehan advised device companies to proceed with caution as they move beyond the gainsharing demonstration project called for in the Deficit Reduction Act of 2005. The demonstration project allows physicians to share in hospital cost savings if they agree to follow certain cost-cutting measures, such as using specific products for which hospitals have negotiated lower prices (1"The Gray Sheet" Jan. 2, 2006, p. 10)...
Advertisement

Related Content

Gainsharing Demo Program, Medicare Imaging Cuts Included In Budget Bill
Gainsharing Demo Program, Medicare Imaging Cuts Included In Budget Bill
Advertisement
UsernamePublicRestriction

Register

MT023402

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel